These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20656359)

  • 21. St. John's wort - an overview.
    Linde K
    Forsch Komplementmed; 2009 Jun; 16(3):146-55. PubMed ID: 19657198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient information materials in general practices and promotion of health literacy: an observational study of their effectiveness.
    Protheroe J; Estacio EV; Saidy-Khan S
    Br J Gen Pract; 2015 Mar; 65(632):e192-7. PubMed ID: 25733441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preference of patient information leaflets over standard drug monographs by patients prescribed hydrochlorothiazide, nifedipine and enalapril.
    Gossell-Williams M; Bennett O; Dias Y; Foster K; Houston M; Wright K; Fairclough Z
    West Indian Med J; 2012 Jun; 61(3):271-9. PubMed ID: 23155986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. About the cover: St. John's wort.
    J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypericum and nurses: a comprehensive literature review on the efficacy of St. John's Wort in the treatment of depression.
    Carpenter C; Crigger N; Kugler R; Loya A
    J Holist Nurs; 2008 Sep; 26(3):200-7; discussion 208-11. PubMed ID: 18424529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation.
    Raynor DK; Svarstad B; Knapp P; Aslani P; Rogers MB; Koo M; Krass I; Silcock J
    J Am Pharm Assoc (2003); 2007; 47(6):717-24. PubMed ID: 18032134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge.
    Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
    PLoS One; 2019; 14(1):e0210395. PubMed ID: 30625196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug information for patients (Package Leaflets), and user testing in EU].
    Yamamoto M; Doi H; Furukawa A
    Yakugaku Zasshi; 2015; 135(2):277-84. PubMed ID: 25747226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient information leaflets: informing or frightening? A focus group study exploring patients' emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices.
    Herber OR; Gies V; Schwappach D; Thürmann P; Wilm S
    BMC Fam Pract; 2014 Oct; 15():163. PubMed ID: 25277783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient information leaflets on over-the-counter (OTC) medicines: the manufacturer's perspective.
    Bradley B; McCusker E; Scott E; Li Wan Po A
    J Clin Pharm Ther; 1995 Feb; 20(1):37-40. PubMed ID: 7775612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological treatment strategies of depression--psychopharmacology and non-pharmacological methods].
    Hatzinger M
    Ther Umsch; 2010 Nov; 67(11):585-91. PubMed ID: 21043020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled clinical trials of hypericum extracts in depressed patients--an overview.
    Volz HP
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():72-6. PubMed ID: 9342763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V; Winterhoff H; Herkenham M
    Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [High dose St. John's wort extract as a phytogenic antidepressant].
    Kasper S; Schulz V
    Wien Med Wochenschr; 1999; 149(8-10):191-6. PubMed ID: 10483679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative importance of informational items in participant information leaflets for trials: a Q-methodology approach.
    Innes K; Cotton S; Campbell MK; Elliott J; Gillies K
    BMJ Open; 2018 Sep; 8(9):e023303. PubMed ID: 30185580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Worth the paper they are printed on? Findings from an independent evaluation of the understandability of patient information leaflets for antiseizure medications.
    Noble AJ; Haddad S; Coleman N; Marson AG
    Epilepsia; 2022 Aug; 63(8):2130-2143. PubMed ID: 35560228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.
    Bjorklund M; Shiely F; Gillies K
    PLoS One; 2022; 17(5):e0268898. PubMed ID: 35609047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of patient information leaflet and perceived impact of its use on medication adherence.
    Al Jeraisy M; Alshammari H; Albassam M; Al Aamer K; Abolfotouh MA
    BMC Public Health; 2023 Mar; 23(1):488. PubMed ID: 36918823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Prescription Drug Information Leaflets: Impact of Cognitive Effort and Patient Involvement on Prescription Medication Information Processing.
    Patel HK; Bapat SS; Bhansali AH; Sansgiry SS
    Ther Innov Regul Sci; 2018 Jan; 52(1):118-129. PubMed ID: 29714618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in England.
    Webster RK; Rubin GJ
    Drug Saf; 2020 Oct; 43(10):1011-1022. PubMed ID: 32557180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.